Shendelman Shoshana's Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Jan 13, 2023
- Accession no.
- 0001209191-23-003290
- Filed
- Jan 13, 2023
- Trade date
- Jan 11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $14.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shendelman ShoshanaCIK 0001775490 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | Common Stock | SSaleDisposed | −15,870 | $0.91 | −$14,441.7 | 751,625 | Direct | |
| Jan 11, 2023 | Common Stock | AGrant or awardAcquired | +1,964,362 | $0.00 | $0 | 2,715,987 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The reporting person has agreed to voluntarily disgorge to the Issuer all statutory "profits" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein.